Vitamin B5 Powder

1. INCI & CAS

INCI: Vitamin B5 Powder · CAS: pending supplier / regulatory confirmation for the selected grade

2. Role in the formula

Vitamin B5 Powder is carried as a named cosmetic ingredient for this SKU. Identity, assay and impurities are confirmed on the supplier TDS and COA. This page does not invent a CAS or a drug effect.

3. Typical use levels (formulation guide)

• Refer to the supplier TDS to establish a suitable level in the finished formula.

Follow the supplier TDS for solvent, temperature and pH.

4. Regulatory sources & global compliance

• A CosIng listing for Vitamin B5 Powder provides ingredient information, not approval of a supplied grade or finished product.
• The finished-product provisions of Regulation (EC) No 1223/2009 require an assessment addressing the safety of the finished product that contains Vitamin B5 Powder in the final product context.
• Use current supplier documentation for the purchased Vitamin B5 Powder grade and verify applicable destination-market filings.

5. Safety & risk assessment

This level is a cosmetic-formulation guide; it does not qualify a finished product as a drug or OTC product with patch and stability testing still needed for the completed formula.

6. Stability & packaging

Keep the ingredient in cool, closed bulk storage away from sunlight; if the formula is oxidation-sensitive, an airless or pump format may be considered; check the finished formula and its packaging together.

7. Claims language (Do / Don’t)

• Names Vitamin B5 Powder as a cosmetic ingredient on this SKU

• The cosmetic listing does not demonstrate claims of drug activity, a clinical cure, or an undocumented product certification.
• The information about Vitamin B5 Powder does not demonstrate whitening, acne treatment, antiperspirant action, sunscreen use, or hair-growth outcomes.

1. INCI & CAS

INCI: Oryza Sativa Powder · CAS: pending supplier / regulatory confirmation for the selected grade

2. Role in the formula

Oryza sativa powder is a cosmetic powder carrier. Enzyme activity, if any, is a separate ingredient.

3. Typical use levels (formulation guide)

• 30–70% of the powder phase is listed for powder cleansers as a formulation guide.

Avoid moisture exposure before the powder is used.

4. Regulatory sources & global compliance

• If Oryza Sativa Powder appears in CosIng, its entry is informational and does not approve a specific grade or finished cosmetic.
• An EU-market cosmetic under Regulation (EC) No 1223/2009 requires the completed product containing Oryza Sativa Powder to receive its own safety assessment for the product in its final form.
• Use the supplier TDS to confirm grade-specific details for Oryza Sativa Powder and review the destination market's requirements.

5. Safety & risk assessment

Treat the listed amount as cosmetic-development guidance; the listed level does not itself confer drug or OTC status with patch response and finished-product stability still to be verified.

6. Stability & packaging

Keep bulk material sealed, cool, and out of direct sunlight; consider an airless or pump format when oxidation sensitivity warrants it; use batch testing to verify stability and package compatibility.

7. Claims language (Do / Don’t)

• The cosmetic formulation concept for Oryza Sativa Powder centers on rice-powder carrier.

• This product entry is not evidence of drug claims, cure claims, or a certification that is absent from the product records.
• The formulation record for Oryza Sativa Powder provides no basis for whitening, acne treatment, antiperspirant action, sunscreen use, or hair-growth outcomes.

1. INCI & CAS

INCI: Sodium Cocoyl Glutamate · CAS: pending supplier / regulatory confirmation for the selected grade

2. Role in the formula

Sodium cocoyl glutamate is a mild anionic surfactant. Activity is on the TDS.

3. Typical use levels (formulation guide)

• Washes: 2–8% in this reference.

Follow the supplied form, liquid or powder.

4. Regulatory sources & global compliance

• If Sodium Cocoyl Glutamate appears in CosIng, its entry is informational and does not approve a specific grade or finished cosmetic.
• Regulation (EC) No 1223/2009 requires an assessment of the safety of the final cosmetic containing Sodium Cocoyl Glutamate in the final product context.
• Review the documentation for the actual Sodium Cocoyl Glutamate grade and the filing requirements for the target market.

5. Safety & risk assessment

The percentage is shown for cosmetic development; the note establishes neither drug approval nor OTC-monograph status and the finished formula still needs patch and stability testing.

6. Stability & packaging

Protect sealed bulk from warmth and direct light; where appropriate, assess an airless or pump pack for oxidation-sensitive systems; then verify formula stability and pack compatibility on the confirmed batch.

7. Claims language (Do / Don’t)

• The cosmetic formulation concept for Sodium Cocoyl Glutamate centers on glutamate surfactant.

• The cosmetic listing is not evidence of drug-treatment outcomes, clinical cures, or certifications not documented for the SKU.
• The formulation record for Sodium Cocoyl Glutamate is not evidence for skin whitening, acne care, sweat reduction, sun protection, or hair-growth outcomes.